IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.

Journal: Cell

Published: 2020-08-17

DOI: 10.1016/j.cell.2020.07.038

Affiliations: 27

Authors: 39

Go to article
Institutions Share
German Consortium of Translational Cancer Research (DKTK), Germany 0.24
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.17
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.09
Heidelberg University (Uni Heidelberg), Germany 0.09
Division of Ecotoxicology, UFZ, Germany 0.08
Mannheim University of Applied Sciences, Germany 0.08
Friedrich Schiller University Jena (FSU), Germany 0.06
National Center for Tumor Diseases (NCT) Heidelberg, Germany 0.05
Berlin Institute of Health (BIH), Germany 0.05
Technische Universität Bergakademie Freiberg (TUBAF), Germany 0.01
Helmholtz Centre for Environmental Research (UFZ), Germany 0.01
Leibniz Institute for Natural Product Research and Infection Biology - Hans-Knöll-Institute (HKI), Germany 0.01
University of Innsbruck (LFU), Austria 0.01
Mohammed VI Polytechnic University, Morocco 0.01
University of Costa Rica (UCR), Costa Rica 0.01
University Medical Center Groningen (UMCG), RUG, Netherlands 0.01
University of Oldenburg, Germany 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER